Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells.
作者信息
Ma Yarui, Zhu Qing, Wang Xiaobing, Liu Mei, Chen Qichen, Jiang Liming, Chi Yihebali, Zeng Yi-Xin, Zhao Hong, Jiao Yuchen
机构信息
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Medical Oncology, Beijing Hospital, National Center of Gerontology and Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
出版信息
Cell Res. 2022 Jun;32(6):596-599. doi: 10.1038/s41422-022-00613-1. Epub 2022 Feb 15.
Abstract
摘要
相似文献
1
Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells.
Cell Res. 2022 Jun;32(6):596-599. doi: 10.1038/s41422-022-00613-1. Epub 2022 Feb 15.
2
Protein S-glutathionylation and sex dimorphic effects on hydrogen peroxide production by dihydroorotate dehydrogenase in liver mitochondria.
Free Radic Biol Med. 2023 Jan;194:123-130. doi: 10.1016/j.freeradbiomed.2022.11.043. Epub 2022 Nov 30.
3
Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth.
ACS Chem Biol. 2021 Nov 19;16(11):2570-2580. doi: 10.1021/acschembio.1c00625. Epub 2021 Nov 3.
4
Inhibition of mitochondrial complex III or dihydroorotate dehydrogenase (DHODH) triggers formation of poly(A) RNA foci adjacent to nuclear speckles following activation of ATM (ataxia telangiectasia mutated).
RNA Biol. 2022 Jan;19(1):1244-1255. doi: 10.1080/15476286.2022.2146919.
5
Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.
Nucleosides Nucleotides Nucleic Acids. 2022;41(12):1337-1358. doi: 10.1080/15257770.2022.2039393. Epub 2022 Feb 20.
6
SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor.
Eur J Med Chem. 2022 Dec 15;244:114826. doi: 10.1016/j.ejmech.2022.114826. Epub 2022 Oct 5.
7
Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.
Free Radic Biol Med. 2022 Nov 20;193(Pt 1):202-212. doi: 10.1016/j.freeradbiomed.2022.10.004. Epub 2022 Oct 10.
8
A first in man study to evaluate the safety, pharmacokinetics and pharmacodynamics of RP7214, a dihydroorotate dehydrogenase inhibitor in healthy subjects.
Br J Clin Pharmacol. 2023 Mar;89(3):1127-1138. doi: 10.1111/bcp.15562. Epub 2022 Nov 1.
9
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.
JCI Insight. 2022 Aug 9;7(17):e153836. doi: 10.1172/jci.insight.153836.
10
-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia.
J Med Chem. 2022 Aug 25;65(16):11241-11256. doi: 10.1021/acs.jmedchem.2c00788. Epub 2022 Aug 4.
引用本文的文献
1
Progress report on multiple endocrine neoplasia type 1.
Fam Cancer. 2025 Jan 18;24(1):15. doi: 10.1007/s10689-025-00440-4.
2
Sporadic Parathyroid Carcinoma Treated With Lenvatinib, Exhibiting a Novel Somatic Mutation.
JCEM Case Rep. 2024 Jul 24;2(8):luae121. doi: 10.1210/jcemcr/luae121. eCollection 2024 Aug.
3
Successful management of a multiple endocrine neoplasia type 1-associated thymic neuroendocrine neoplasms with acute chest pain as initial symptom: A rare case report.
Clin Case Rep. 2024 Jun 14;12(6):e9031. doi: 10.1002/ccr3.9031. eCollection 2024 Jun.
4
Dehydroabietylamine exerts antitumor effects by affecting nucleotide metabolism in gastric cancer.
Carcinogenesis. 2024 Oct 10;45(10):759-772. doi: 10.1093/carcin/bgae037.
5
Classical swine fever virus non-structural protein 4A recruits dihydroorotate dehydrogenase to facilitate viral replication.
J Virol. 2024 Jun 13;98(6):e0049424. doi: 10.1128/jvi.00494-24. Epub 2024 May 17.
6
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer.
Oncogene. 2024 May;43(19):1399-1410. doi: 10.1038/s41388-024-03005-4. Epub 2024 Mar 13.
7
Ferroptosis: a new hunter of hepatocellular carcinoma.
Cell Death Discov. 2024 Mar 13;10(1):136. doi: 10.1038/s41420-024-01863-1.
8
Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment.
Cancer Biol Med. 2023 Sep 28;20(10):721-7. doi: 10.20892/j.issn.2095-3941.2023.0284.
9
Small molecule inhibitors for cancer metabolism: promising prospects to be explored.
J Cancer Res Clin Oncol. 2023 Aug;149(10):8051-8076. doi: 10.1007/s00432-022-04501-4. Epub 2023 Mar 31.
10
Optimization of CRISPR-Cas system for clinical cancer therapy.
Bioeng Transl Med. 2022 Dec 23;8(2):e10474. doi: 10.1002/btm2.10474. eCollection 2023 Mar.
Zotero 插件